A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Most children are happy to let their teeth come out naturally but for one Florida boy, a little extra horsepower was called on.
Travellers hoping to get away for the Easter weekend are being warned of potentially serious problems on the road and rail networks.
Left-footed footballs, backwards web searches, police camels and an eco-friendly Jeremy Clarkson are among today's traditional tall tales.